Jansen Burkhard 4
4 · DermTech, Inc. · Filed Jan 28, 2021
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Jansen Burkhard
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-26$6.94/sh+5,000$34,700→ 79,037 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-26−5,000→ 16,244 totalExercise: $6.94Exp: 2026-03-14→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]This reported disposition reflects the exercise of an option. The shares of common stock issued upon exercise of this option remain subject to the restrictions contemplated by the lock-up agreement, dated January 1, 2021, by and among the reporting person, the issuer, and the representatives of the several underwriters of the issuer's January 2021 public offering of common stock.
- [F2]This option is fully vested and exercisable.